Getting to 90-90-90 in Paediatric HIV: What is Needed?

Overview

Journal J Int AIDS Soc

Specialty Infectious Diseases

Date 2017 Mar 23

PMID 28326130

Citations 11

Authors

Mary-Ann Davies

Jorge Pinto

Marlene Bras

Affiliations

Soon will be listed here.

Citing Articles

Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study.

Musiime-Mwase F, Nakanjako D, Kanywa J, Nasuuna E, Naitala R, Oceng R BMC Infect Dis. 2024; 24(1):1057.

PMID: 39333946 PMC: 11429377. DOI: 10.1186/s12879-024-09930-9.

Evidence-based service delivery interventions for testing, linking, treating, and retaining children and adolescents living with HIV in primary health care settings: Protocol for a systematic review.

Putta N, Hansen C, Funaro M, Campbell M, Essajee S, Mbori-Ngacha D PLoS One. 2022; 17(6):e0269063.

PMID: 35709211 PMC: 9202933. DOI: 10.1371/journal.pone.0269063.

Involvement of Male Partners of Pregnant Women in the Prevention of Mother-to-Child Transmission (PMTCT) of HIV in Haiti: A Mixed-Methods Study.

Ngangue P, Fleurantin M, Adekpedjou R, Philibert L, Gagnon M Am J Mens Health. 2021; 15(2):15579883211006003.

PMID: 33874810 PMC: 8060766. DOI: 10.1177/15579883211006003.

An open-source molecular diagnostic platform approach for outbreak and epidemic preparedness.

Emperador D, Mazzola L, Kelly-Cirino C Afr J Lab Med. 2020; 9(2):1017.

PMID: 33102172 PMC: 7564747. DOI: 10.4102/ajlm.v9i2.1017.

Perceived Barriers Toward Provider-Initiated HIV Testing and Counseling (PITC) in Pediatric Clinics: A Qualitative Study Involving Two Regional Hospitals in Dar-Es-Salaam, Tanzania.

Marwa R, Anaeli A HIV AIDS (Auckl). 2020; 12:141-150.

PMID: 32280281 PMC: 7127846. DOI: 10.2147/HIV.S235818.

References

Babl F, Regan A, Pelton S . Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals. Lancet. 1999; 353(9160):1243-4. DOI: 10.1016/S0140-6736(98)05754-7. View

Mirochnick M, Nielsen-Saines K, Pilotto J, Pinto J, Veloso V, Rossi S . Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. Pediatr Infect Dis J. 2011; 30(9):769-72. PMC: 3158246. DOI: 10.1097/INF.0b013e3182242950. View

Singh P, Sachs J . 1 million community health workers in sub-Saharan Africa by 2015. Lancet. 2013; 382(9889):363-5. DOI: 10.1016/S0140-6736(12)62002-9. View

Paramesparan Y, Garvey L, Ashby J, Foster C, Fidler S, Winston A . High rates of asymptomatic neurocognitive impairment in vertically acquired HIV-1-infected adolescents surviving to adulthood. J Acquir Immune Defic Syndr. 2010; 55(1):134-6. DOI: 10.1097/QAI.0b013e3181d90e8c. View

Alves C, Oliveira A, Brites C . Lipodystrophic syndrome in children and adolescents infected with the human immunodeficiency virus. Braz J Infect Dis. 2008; 12(4):342-8. DOI: 10.1590/s1413-86702008000400018. View

van Dijk J, Sutcliffe C, Munsanje B, Sinywimaanzi P, Hamangaba F, Thuma P . HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One. 2011; 6(4):e19006. PMC: 3084269. DOI: 10.1371/journal.pone.0019006. View

Colditz G, Brewer T, Berkey C, Wilson M, Burdick E, Fineberg H . Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994; 271(9):698-702. View

Kankasa C, Carter R, Briggs N, Bulterys M, Chama E, Cooper E . Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr. 2009; 51(2):202-8. PMC: 5117627. DOI: 10.1097/qai.0b013e31819c173f. View

Hesseling A, Cotton M, von Reyn C, Graham S, Gie R, Hussey G . Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants. Int J Tuberc Lung Dis. 2008; 12(12):1376-9. View

10.

Grody W, Cheng L, Lewis W . Infection of the heart by the human immunodeficiency virus. Am J Cardiol. 1990; 66(2):203-6. DOI: 10.1016/0002-9149(90)90589-s. View

11.

Edginton A, Schmitt W, Voith B, Willmann S . A mechanistic approach for the scaling of clearance in children. Clin Pharmacokinet. 2006; 45(7):683-704. DOI: 10.2165/00003088-200645070-00004. View

12.

Lallemant M, Chang S, Cohen R, Pecoul B . Pediatric HIV--a neglected disease?. N Engl J Med. 2011; 365(7):581-3. DOI: 10.1056/NEJMp1107275. View

13.

Townsend C, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H . Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014; 28(7):1049-57. DOI: 10.1097/QAD.0000000000000212. View

14.

Holzemer W, Uys L, Makoae L, Stewart A, Phetlhu R, Dlamini P . A conceptual model of HIV/AIDS stigma from five African countries. J Adv Nurs. 2007; 58(6):541-51. DOI: 10.1111/j.1365-2648.2007.04244.x. View

15.

van Zyl G, van der Merwe L, Claassen M, Cotton M, Rabie H, Prozesky H . Protease inhibitor resistance in South African children with virologic failure. Pediatr Infect Dis J. 2009; 28(12):1125-7. DOI: 10.1097/INF.0b013e3181af829d. View

16.

Little K, Thorne C, Luo C, Bunders M, Ngongo N, McDermott P . Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res. 2007; 5(2):139-53. DOI: 10.2174/157016207780077002. View

17.

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

18.

Yotebieng M, Van Rie A, Moultrie H, Cole S, Adimora A, Behets F . Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS. 2010; 24(9):1341-9. PMC: 5161025. DOI: 10.1097/QAD.0b013e328339e576. View

19.

Bagenda D, Nassali A, Kalyesubula I, Sherman B, Drotar D, Boivin M . Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics. 2006; 117(3):729-40. DOI: 10.1542/peds.2004-2699. View

20.

Charpentier C, Gody J, Mbitikon O, Moussa S, Matta M, Pere H . Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. AIDS Res Hum Retroviruses. 2011; 28(1):87-94. DOI: 10.1089/aid.2011.0035. View